症例で覚えるPCI術者に必要な治療Tips

出版社: メジカルビュー社
著者:
発行日: 2015-10-10
分野: 臨床医学:内科  >  呼吸器一般
ISBN: 9784758314275
電子書籍版: 2015-10-10 (第1版第1刷)
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安:8~14営業日

8,250 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

8,250 円(税込)

商品紹介

掲載した症例はいずれもPCI術者であれば誰もが遭遇しうる治療方針の決定に迷うケースではないかと思われます。日常臨床でわれわれが治療する個々の患者には様々な全身疾患もしくは特異な病変背景を併せもつ場合が多くいわゆるEBMだけに基づいた治療は難しい場合が多いと考えられます。本書では,日々遭遇しうるさまざまな臨床もしくは病変の背景をもつ患者への一例一例の臨床経験から得られた知見を,全国のエキスパートのPCI術者から提示していただき,特に,症例数の豊富でない施設の術者や経験数のいまだ少ない若手術者への日々のPCI臨床の手助けとなる知識,判断,応用に役立つ書を編集いたしました。

目次

  • 症例で覚えるPCI術者に必要な治療Tips

    ―目次―

    I 他疾患が併存する冠動脈疾患へのPCI治療の考え方
     腎機能障害を伴う症例
     肝硬変を伴う症例へのPCI
     年齢を考慮したPCI治療
     金属アレルギー患者に対するPCI治療
     担癌患者へのPCI治療
     非心臓手術を控えた患者へのPCI治療

    II ACSに対するPCI治療の考え方
     重症心原性ショックを伴う症例
     左冠動脈前下行枝入口部閉塞
     大量の血栓を伴う症例
     不安定狭心症へのPCI治療

    III 全身の動脈硬化を伴う冠動脈病変へのPCI治療の考え方
     大動脈疾患を合併
     重症PADを合併した患者へのPCI

    IV 特殊な冠動脈病変に対するPCI治療の考え方
     病変部位
     高度心機能低下(EF20%)を認めた心不全合併症例
     弁膜症合併症例
     起始異常を伴う冠動脈病変へのPCI
     ロータブレーター施設基準を満たさない施設での
      石灰化病変へのPCI
     川崎病に伴う冠動脈病変へのPCI

    V PCI時にきたした重症合併症への対応
     HIT症候群への対応
     左冠動脈主幹部での冠動脈穿孔への対応
     デバイス抜去困難時の対処法

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I 他疾患が併存する冠動脈疾患へのPCI治療の考え方

P.13 掲載の参考文献
1) Lameire N, Adam A, Becker CR, et al ; CIN Consensus Working Panel : Baseline renal function screening. Am J Cardiol 98 (6A) : 21K-26K, 2006.
3) Mehran R, Aymong ED, Nikolsky E, et al : A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention : development and initial validation. J Am Coll Cardiol 44 (7) : 1393-1399, 2004.
4) Abe M, Kimura T, Morimoto T, et al : Incidence of and risk factors for contrast-induced nephropathy after cardiac catheterization in Japanese patients. Circ J 73 (8) : 1518-1522, 2009.
5) Gruberg L, Mintz GS, Mehran R, et al : The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36 (5) : 1542-1548, 2000.
6) Brown JR, Malenka DJ, DeVries JT, et al ; Dartmouth Dynamic Registry Investigators. Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention : insights from the Dartmouth Dynamic Registry. Catheter Cardiovasc Interv 72 (3) : 347-354, 2008.
7) Barrett BJ, Carlisle EJ : Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 188 (1) : 171-178, 1993.
8) Trivedi HS, Moore H, Nasr S, et al : A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93 (1) : C29-34, 2003.
P.19 掲載の参考文献
1) Rihal CS, Textor SC, Grill DE, et al : Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105 : 2259-2264, 2002.
2) 塩田裕啓, 三好 優, 羽田野かおり, ほか : 術中・術後の高灌流持続的血液ろ過透析による心カテ時の造影剤起因性腎症予防についての検討. CVIT Jpn Ed 5 : 117-123, 2013.
3) Marenzi G, Lauri G, Campodonico J, et al : Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med 119 : 155-162, 2006.
4) Mehran R, Aymong ED, Nikolsky E, et al : A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention : development and initial validation. J Am Coll Cardiol 44 : 1393-1399, 2004.
5) Tepel M, van der Giet M, Schwarzfeld C, et al : Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343 : 180-184, 2000.
6) Brar SS, Shen AY, Jorgensen MB, et al : Sodium bicarbonate vs sodium chloride for prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography. a randomized trial. JAMA 300 : 1038-1046, 2008.
7) Maioli M, Toso A, Leoncini M, et al : Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 52 (8) : 599-604, 2008.
P.24 掲載の参考文献
1) Marui A, Mimura T, Nishiwaki N, et al : Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG registry cohort-2). Am J Cardiol 114 : 555-561, 2014.
2) 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 35 : 2541-2619, 2014.
3) Sardi GL, Maluenda G, Torguson R, et al : Impact of diabetes mellitus on long-term clinical outcomes of patients on chronic hemodialysis after percutaneous coronary intervention. J Interv Cardiol 25 : 147-155, 2012.
4) Kitahara H, Kobayashi Y, Yamaguchi M, et al : Damage to polymer of paclitaxel-eluting stent. Circ J 72 : 1907-1908, 2008.
P.32 掲載の参考文献
1) Bosserhoff A, Hellerbrand C : Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis. Dig Dis 29 : 377-383, 2011.
2) D'Amico G1, Garcia-Tsao G, Pagliaro L : Natural history and prognostic indicators of survival in cirrhosis : a systematic review of 118 studies. J Hepatology 44 : 217-231, 2006.
3) Kamath PS, Wiesner RH, Malinchoc M, et al : A model to predict survival in patients with end-stage liver disease. Hepatology 33 : 464-470, 2001.
4) Rios R, Sangro B, Herrero I, et al : The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis. Am J Gastroenterol 100 (6) : 1311-1316, 2005.
5) Tripodi A, Mannucci PM : The coagulopathy of chronic liver disease. N Engl J Med 365 : 147-156, 2011.
6) Bizouarn P, Ausseur A, Desseigne P, et al : Early and late outcome after elective cardiac surgery in patients with cirrhosis. Ann Thorac Surg 67 : 1334-1338, 1999.
7) Filsoufi F, Salzberg SP, Rahmanian PB, et al : Early and late outcome of cardiac surgery in patients with liver cirrhosis. Liver transp 13 : 990-995, 2007.
8) Marui A, Kimura T, Tanaka S, et al : Coronary revascularization in patients with liver cirrhosis. Ann Thorac Surg 91 : 1393-1399, 2011.
P.39 掲載の参考文献
1) Lerner DJ, Kannel WB : Patterns of coronary heart disease morbidity and mortality in the sexes : a 26-year follow-up of the Framingham population. Am Heart J 111 : 383-390, 1986.
2) Yu J, Mehran R, Grinfeld L, et al : Sex-based differences in bleeding and long-term adverse events after percutaneous coronary intervention for acute myocardial infarction : three-year results from the HORIZONS-AMI trial. Catheter Cardiovasc Interv 85 : 359-368, 2014.
3) Rao SV, Hess CN, Barham B, et al : A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention : the study of access site for enhancement of PCI for women (SAFE-PCI for Women) trial. J Am Coll Cardiol Intrv 7 : 857-867, 2014.
4) Davies MJ : The composition of coronary-artery plaques. N Engl J Med 336 : 1312-1314, 1997.
5) Burke AP, Farb A, Malcom GT, et al : Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation 97 : 2110-2116, 1998.
6) Kosuge M, Kimura K, Ishikawa T, et al : Differences be- tween men and women in terms of clinical features of ST-segment elevation acute myocardial infarction. Circ J 70 : 222-226, 2006.
7) DeVon HA, Zerwic JJ : Symptoms of acute coronary syndromes : are there gender differences? A review of the literature. Heart Lung 31 : 235-245, 2002.
8) Philpott S, Boynton PM, Feder G, et al : Gender differences in descriptions of angina symptoms and health problems immediately prior to angiography : the ACRE study. Appropri- ateness of Coronary Revascularisation study. Soc Sci Med 52 : 1565-1575, 2001.
9) Pundziute G, Schuijf JD, Jukema JW, et al : Gender influence on the diagnostic accuracy of 64-slice multislice computed tomography coronary angiography for detection of obstructive coronary artery disease. Heart 94 : 48-52, 2008.
10) Ouyang P, Michos ED, Karas RH : Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions. J Am Coll Cardiol 47 : 1741-1753, 2006.
11) Kawano H, Motoyama T, Ohgushi M, et al : Menstrual cyclic variation of myocardial ischemia in premenopausal women with variant angina. Ann Intern Med 135 : 977-981, 2001.
12) Kawano H, Motoyama T, Kugiyama K, et al : Menstrual cyclic variation of endothelium-dependent vasodilation of the brachial artery : possible role of estrogen and nitric oxide. Proc Assoc Am Physicians 108 : 473-480, 1996.
13) Manzi S, Meilahn EN, Rairie JE, et al : Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus : comparison with the Framingham Study. Am J Epidemiol 145 (5) : 408-415, 1997.
14) Koul AK, Hollander G, Moskovits N, et al : Coronary artery dissection during pregnancy and the postpartum period : two case reports and review of literature. Catheter Cardiovasc Interv 52 : 88-94, 2001.
15) Appleby CE, Barolet A, Ing D, et al : Contemporary man- agement of pregnancy-related coronary artery dissection : A single-centre experience and literature review. Exp Clin Cardiol 14 : e8-e16, 2009.
P.46 掲載の参考文献
1) Konishi H, Miyauchi K, Kasai T, et al : Long-term prognosis and clinical characteristics of young adults (</=40 years old) who underwent percutaneous coronary intervention. J Cardiol 64 : 171-174, 2014.
2) Strong JP, Malcom GT, McMahan CA, et al : Prevalence and extent of atherosclerosis in adolescents and young adults : implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. Jama 281 : 727-735, 1999.
3) Meliga E, De Benedictis M, Gagnor A, et al : Long-term outcomes of percutaneous coronary interventions with stent implantation in patients </=40 years old. Am J Cardiol 109 : 1717-1721, 2012.
4) Chen SM, Tsai TH, Hang CL, et al : Endothelial dysfunction in young patients with acute ST-elevation myocardial infarction. Heart and vessels 26 : 2-9, 2011.
5) Flather M, Rhee JW, Boothroyd DB, et al : The effect of age on outcomes of coronary artery bypass surgery compared with balloon angioplasty or bare-metal stent implantation among patients with multivessel coronary disease. A collaborative analysis of individual patient data from 10 randomized trials. J Am Coll Cardiol 60 : 2150-2157, 2012.
6) Head SJ, Davierwala PM, Serruys PW, et al : Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease : final five-year follow-up of the SYNTAX trial. Eur Heart J 35 : 2821-2830, 2014.
7) Khawaja FJ, Rihal CS, Lennon RJ, et al : Temporal trends (over 30 years), clinical characteristics, outcomes, and gender in patients </=50 years of age having percutaneous coronary intervention. Am J Cardiol 107 : 668-674, 2011.
8) Garcia-Labbe D, Ruka E, Bertrand OF, et al : Obesity and coronary artery disease : evaluation and treatment. Can J Cardiol 31 : 184-194, 2015.
9) Shiraishi J, Kohno Y, Sawada T, et al : Pathogenesis of acute myocardial infarction in young male adults with or without obesity. J Cardiol 49 : 13-21, 2007.
P.53 掲載の参考文献
1) Lee PY, Alexander KP, Hammill BG, et al : Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 286 : 708-713, 2001.
2) Magid DJ, Masoudi FA, Vinson DR, et al : Older emergency department patients with acute myocardial infarction receive lower quality of care than younger patients. Ann Emerg Med 46 : 14-21, 2005.
3) Mehta RH, Rathore SS, Radford MJ, et al : Acute myocardial infarction in the elderly : differences by age. J Am Coll Cardiol 38 : 736-741, 2001.
4) Rathore SS, Mehta RH, Wang Y, et al : Effects of age on the quality of care provided to older patients with acute myocardial infarction. Am J Med 114 : 307-315, 2003.
5) Schoenenberger AW, Radovanovic D, Stauffer JC, et al : Age-related differences in the use of guideline-recommended medical and interventional therapies for acute coronary syndromes : a cohort study. J Am Geriatr Soc 56 : 510?516, 2008.
6) de Boer SP, Westerhout CM, Simes RJ, et al : Mortality and morbidity reduction by primary percutaneous coronary intervention is independent of the patient's age. JACC Cardiovasc Interv 3 : 324-331, 2010.
P.59 掲載の参考文献
1) Koster R, Vieluf D, Kiehn M, et al : Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 356 : 1895-1897, 2000.
2) Iijima R, Ikari Y, Amiya E, et al : The impact of metallic allergy on stent implantation : Metal allergy and recurrence of in-stent restenosis. Int J Cardiol 104 : 319-325, 2005.
3) Nakazawa G, Tanabe K, Aoki J, et al : Sirolimus-eluting stents suppress neointimal formation irrespective of metallic allergy. Circ J 72 : 893-896, 2008.
P.65 掲載の参考文献
1) 許俊鋭, 今中和人, 上田裕一, ほか : 非心臓手術における合併心疾患の評価と管理に関するガイドライン. Circ J 75 : 989-1009, 2008.
2) Fleisher LA, Beckman JA, Brown KA, et al : 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery : a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation 120 : e169-276, 2009.
3) Cheneau E, Leborgne L, Mintz GS, et al : Predictors of Subacute Stent Thrombosis Results of a Systematic Intravascular Ultrasound Study. Circulation 108 : 43-47, 2003.
4) Uren NG, Schwarzacher SP, Metz JA, et al : Predictors and outcomes of stent thrombosis : an intravascular ultrasound registry. Eur Heart J 23 : 124-132, 2002.
P.77 掲載の参考文献
1) Kaluza GL, Joseph J, Lee JR, et al : Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35 : 1288-1294, 2000.
2) McFalls EO, Ward HB, Moritz TE, et al : Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 351 : 2795-2804, 2004.
3) Poldermans D, Schouten O, Vidakovic R, et al : A clinical randomized trial to evaluate the safety of a non-invasive approach in high-risk patients undergoing major vascular surgery : the DECREASE-V Pilot Study. J Am Coll Cardiol 49 : 1763-1769, 2007.
4) Kristensen SD, Knuuti J : New ESC/ESA Guidelines on non-cardiac surgery : cardiovascular assessment and management. Eur Heart J 35 : 2344-2345, 2014.
5) Poldermans D, Boersma E, Bax JJ, et al : The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341 : 1789-1794, 1999.
6) Devereaux PJ, Yang H, Yusuf S, et al : Effects of extended-release metoprolol succinate in patients undergoing noncardiac surgery (POISE trial) : a randomised controlled trial. Lancet 371 : 1839-1847, 2008.
7) Lindenauer PK, Pekow P, Wang K, et al : Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 353 : 349-361, 2005.
8) Bangalore S, Wetterslev J, Pranesh S, et al : Perioperative beta blockers in patients having non-cardiac surgery : a meta-analysis. Lancet 372 : 1962-1976, 2008.
9) Bouri S, Shun-Shin MJ, Cole GD, et al : Meta-analysis of secure randomised controlled trials of beta-blockade to prevent perioperative death in non-cardiac surgery. Heart 100 : 456-464, 2014.
10) London MJ, Hur K, Schwartz GG, Henderson WG : Association of perioperative beta-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA 309 : 1704-1713, 2013.
11) Schouten O, Boersma E, Hoeks SE, et al : Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med 361 : 980-989, 2009.
12) Tokushige A, Shiomi H, Morimoto T, et al ; CREDO-Kyoto PCI/CABG registry cohort-2 investigators : Incidence and outcome of surgical procedures after coronary bare-metal and drug-eluting stent implantation : a report from the CREDO-Kyoto PCI/CABG registry cohort-2. Circ Cardiovasc Interv 5 : 237-246, 2012.
13) Hawn MT, Graham LA, Richman JS, et al : Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA 310 : 1462-1472, 2013.
14) Albaladejo P, Marret E, Samama CM, et al : Non-cardiac surgery in patients with coronary stents : the RECO study. Heart 97 : 1566-1572, 2011.

II ACSに対するPCI治療の考え方

P.87 掲載の参考文献
1) Lee MS, Dahodwala MQ : Percutaneus coronary intervention for acute myocardial infarction due to unprotected left main coronary artery occlusion : Status Update 2014. Catheter Cardiovasc Interv 85 : 416-420, 2015.
2) 風谷幸男 : 左主幹部を梗塞責任病変とする急性心筋梗塞に対する治療戦略. 『PCIのコツと落とし穴』 (一色高明, 編). 中山書店, 東京, 2005, p152-153.
3) Izumikawa T, Sakamoto S, Takeshita S, et al : Outcome of primary percutaneous coronary intervention for acute myocardial infarction with unprotected left main coronary artery occlusion. Catheter Cardiovasc Interv 79 : 1111-1116, 2012.
4) Aoyama N, Imai H, Kurosawa T, et al : Therapeutic strategy using extracorporeal life support, including appropriate indication, management, limitation and timing of switch to ventricular assist device in patients with acute myocardial infarction. J Artif Organs 17 : 33-41, 2014.
5) 倉島直樹, 荒井裕国 : IABPの原理と最新技術動向. CIRCULATION Up-to-Date 第5巻増刊 : 22-28, 2010.
6) 赤羽正史, 平山篤志 : PCPSの定義と原理. CIRCULATION Up-to-Date 第5巻増刊 : 80-84, 2010.
7) 武川博昭 : 左主幹部急性心筋梗塞に対するPCI. Coronary Intervention 6 (5) : 17-24, 2010.
P.93 掲載の参考文献
1) Kosuge M, Ebina T, Hibi K, et al : An early and simple predictor of severe left main and/or three-vessel disease in patients with non-ST-segment elevation acute coronary syndrome. Am J Cardiol 107 : 495-500, 2011.
2) Shiomi H, Nakagawa Y, Morimoto T, et al : CREDO-Kyoto AMI investigators. Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention : observational study. BMJ 344 : e3257, 2012.
3) Hochman JS, Sleeper LA, Webb JG, et al : Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergency Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 341 : 625-634, 1999.
4) Patel MR, Smalling RW, Thiele H, et al : Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock : the CRISP AMI randomized trial. JAMA 306 : 1329-1337, 2011.
5) Kushner FG, Hand M, Smith SC Jr, et al : 2009 focused updates : ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction with (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 54 : 2205-2241, 2009.
6) Thiele H, Zeymer U, Neumann FJ, et al : Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367 : 1287-1296, 2012.
7) Sheu JJ, Tsai TH, Lee FY, et al : Early extra corporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock. Crit Care Med 38 : 1810-1817, 2010.
8) 藤原久義, 一色高明, 大野貴之, ほか : 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 安定冠動脈疾患における待機的PCIのガイドライン (2011年改訂版). <http://www.j-circ.or.jp/guideline/pdf/JCS2011_fujiwara_h.pdf> Accessed Mar.15, 2015.
9) 木村一雄, 浅井徹, 小川久雄, ほか : 循環器病の診断と治療に関するガイドライン (2012年度合同研究班報告). ST上昇型急性心筋梗塞の診療に関するガイドライン (2013年改訂版). <http://www.j-circ.or.jp/guideline/pdf/JCS2013_kimura_h.pdf> Accessed Mar.15, 2015.
10) Bauer T, Zeymer U, Hochadel M, et al : Use and outcomes of multivessel percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock (from the EHS-PCI Registry). Am J Cardiol 109 : 941-946, 2012.
P.99 掲載の参考文献
1) O'Gara PT, Kushner FG, Casey DE, et al : 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. J Am Coll Cardiol 61 : e78-140, 2013.
2) Kumbhani DJ, Bavry AA, Desai MY, et al : Role of Aspiration and Mechanical Thrombectomy in Patients With Acute Myocardial Infarction Undergoing Primary Angioplasty. J Am Coll Cardiol 62 : 1409-1418, 2013.
3) Frobert O, Lagerqvist B, Olivecrona GK, et al : Thrombus Aspiration during ST-Segment Elevation Myocardial Infarction. N Engl J Med 369 : 1587-1597, 2013.
4) Takahashi A, Sakamoto S, Taniguchi N : Thrombus Aspiration With Microcatheter for Distal Embolization During Primary Angioplasty for Acute Myocardial Infarction : Technical Notes. J Invasive Cardiol 24 (11) : 618-621, 2012.
P.105 掲載の参考文献
1) Hochman JS, Sleeper LA, Webb JG, et al : Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 341 : 625-634, 1999.
2) Bonnefoy E, Lapostolle F, Leizorovicz A, et al : Primarybangioplasty versus prehospital fibrinolysis in acute myocardialbinfarction : a randomised study. Lancet 360 : 825-829, 2002.
3) Widimsky P, Budesinsky T, Vorac D, et al : Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J 24 : 94-104, 2003.
4) Steg PG, Bonnefoy E, Chabaud S, et al : Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty : data from the CAPTIM randomized clinical trial. Circulation 108 : 2851-2856, 2003.
5) Saber RS, Edwards WD, Bailey KR, et al : Coronary embolization after balloon angioplasty or thrombolytic therapy : an autopsy study of 32 cases. J Am Coll Cardiol 22 : 1283-1288, 1993.
6) Henriques JP, Zijlstra F, Ottervanger JP, et al : Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 23 : 1112-1117, 2002.
7) Svilaas T, Vlaar PJ, van der Horst IC, et al : Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 358 : 557-567, 2008.
8) Ikari Y, Sakurada M, Kozuma K, et al : Upfront thrombus aspiration in primary coronary intervention for patients with ST-segment elevation acute myocardial infarction : report of the VAMPIRE (VAcuuM asPIration thrombus REmoval) trial. JACC Cardiovasc Interv 1 : 424-431, 2008.
9) Nakatani D, Sato H, Sakata Y, et al : Effect of intracoronary thrombectomy on 30-day mortality in patients with acute myocardial infarction. Am J Cardiol 100 : 1212-1217, 2007.
10) Burzotta F, De Vita M, Gu YL, et al : Clinical impact of thrombectomy in acute ST-elevation myocardial infarction : an individual patient-data pooled analysis of 11 trials. Eur Heart J 30 : 2193-2203, 2009.
11) Stone GW, Webb J, Cox DA, et al : Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction : a randomized controlled trial. JAMA 293 : 1063-1072, 2005.
12) Bavry AA, Kumbhani DJ, Bhatt DL : Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction : a comprehensive meta-analysis of randomized trials. Eur Heart J 29 : 2989-3001, 2008.
13) Kawasaki M, Hirano K : TURBO 吸引療法についての検討. 京都桂病院ペリフェラルCTOセミナー 2010 ; 109-114.
P.113 掲載の参考文献
1) Windecker S, Kolh P, Alfonso F, et al : 2014 ESC/EACTS Guidelines on myocardial revascularization : The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35 (37) : 2541-619, 2014.
2) Morrison DA, Sethi G, Sacks J, et al : Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass : a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). J Am Coll Cardiol 38 (1) : 143-149, 2001.
3) Brilakis ES, Lasala JM, Cox DA, et al : Outcomes after implantation of the TAXUS paclitaxel-eluting stent in saphenous vein graft lesions : results from the ARRIVE (TAXUS Peri-Approval Registry : A Multicenter Safety Surveillance) program. JACC Cardiovasc Interv 3 (7) : 742-750, 2010.
4) Baim DS, Wahr D, George B, et al : Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 105 (11) : 1285-1290, 2002.
5) Stone GW, Rogers C, Hermiller J, et al : Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aortocoronary bypass grafts. Circulation 108 (5) : 548-553, 2003.
6) Brennan JM, Al-Hejily W, Dai D, et al : Three-year outcomes associated with embolic protection in saphenous vein graft intervention : results in 49325 senior patients in the Medicare-linked National Cardiovascular Data Registry CathPCI Registry. Circ Cardiovasc Interv 8 (3) : e001403, 2015.
7) Frobert O, Schersten F, James SK, et al : Long-term safety and efficacy of drug-eluting and bare metal stents in saphenous vein grafts. Am Heart J 164 (1) : 87-93, 2012.
8) Mehilli J, Pache J, Abdel-Wahab M, et al : Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG) : a randomised controlled superiority trial. Lancet 378 (9796) : 1071-1078, 2011.
9) Nauta ST, Van Mieghem NM, Magro M, et al : Seven-year safety and efficacy of the unrestricted use of drug-eluting stents in saphenous vein bypass grafts. Catheter Cardiovasc Interv 79 (6) : 912-918, 2012.
P.121 掲載の参考文献
1) Delewi R, Ijff G, van de Hoef TP, et al : Pathological Q waves in myocardial infarction in patients treated by primary PCI. JACC Cardiovasc Imaging 6 (3) : 324-331, 2013.
2) Rokos IC, French WJ, Mattu A, et al : Appropriate cardiac cath lab activation : optimizing electrocardiogram interpretation and clinical decision-making for acute ST-elevation myocardial infarction. Am Heart J 160 (6) : 995-1003, 2010.
3) Suzuki N, Motoyoshi K, Kozuma, et al : [Cardiac rupture caused by myocardial infarction in the diagonal branch area : evaluation by cardiac multislice computed tomography : a case report]. J Cardiol 46 (2) : 71-76, 2005 Japanese
4) Huang WC, Chiou KR, Liu CP, et al : Multidetector row computed tomography can identify and characterize the occlusive culprit lesions in patients early (within 24 hours) after acute myocardial infarction. Am Heart J 154 (5) : 914-922, 2007.
P.129 掲載の参考文献
1) Sabatine MS, Morrow DA, Giugliano RP, et al : Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction : a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS) -TIMI 18 trial. Circulation 109 : 874-880, 2004.
2) Fox KA, Dabbous OH, Goldberg RJ, et al : Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome : prospective multinational observational study (GRACE). BMJ 333 : 1091-1094, 2006.
3) Lagerqvist B, Husted S, Kontny F, et al : 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome : a follow-up study. Lancet 368 (9540) : 998-1004, 2006.
4) Morice MC, Serruys PW, Kappetein AP, et al : Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 121 : 2645-2653, 2010.
5) 非ST上昇型急性冠症候群の診療に関するガイドライン (2012年改訂版). 循環器病の診断と治療に関するガイドライン (2011年度合同研究班報告).
6) 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary SyndromesA Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 64 (24) : e139-e228, 2014.
7) Palmerini T, Biondi-Zoccai G, Della Riva D, et al : Stent thrombosis with drug-eluting and bare-metal stents : evidence from a comprehensive network meta-analysis. Lancet 379 : 1393-1402, 2012.
P.137 掲載の参考文献
1) Wu X, Mintz GS, Xu K, et al : The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction : the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. JACC Cardiovasc Interv 4 : 495-502, 2011.
2) Park SJ, Kang SJ, Virmani R, et al : In-stent neoatherosclerosis : a final common pathway of late stent failure. JACC 59 (23) : 2051-2057, 2012.
3) Stone GW, Maehara A, Lansky AJ, et al : A prospective natural-history study of coronary atherosclerosis. NEJM 364 : 226-235, 2011.
4) Tanaka A, Imanishi T, Kitabata H, et al : Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome : an optical coherence tomography study. Eur Heart J 30 : 1348-1355, 2009.

III 全身の動脈硬化を伴う冠動脈病変へのPCI治療の考え方

P.153 掲載の参考文献
1) Hollier LH, Kazmier FJ, Ochsner J, et al : Shaggy aorta syndrome with atheromatous embolization to visceral vessels. Ann Vasc Surg 5 : 439-444,1991.
3) Kashinath BS, Corwin HL, Bidani AK, el al : Eosinophilia in the diagnosis of atheroembolic renal disease. Am J Nephrol 7 : 173-177, 1987.
4) 井上多恵, 谷田宗男, 岡田理, ほか : 足肢の凍瘡様紅斑を呈し, 腎症状を伴ったコレステロール結晶塞栓症の1例. 皮膚臨床, 41 : 1803-1806, 1999.
5) Fukumoto Y, Tsutui H, Tsuchihashi M, et al : The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization : a prospective study. J Am coll Cardiol 42 : 211-216, 2003.
6) 大西泰彦 : コレステロール血栓塞栓症. 皮膚臨床, 42 特 : 1552-1555, 2000.
7) Fine MJ, Kapoor W, Falanga V : Cholesterol crystal embolization : a review of 221 cases in the English literature. Angiology 38 : 769-784,1987.
8) Dahlberg PJ, Frecentese DF, Cogbill TH : Cholesterol embolism : experience with 22 historical proven cases. Surgery 105 : 737-746, 1989.
P.165 掲載の参考文献
1) Windecker S, Kohl P, Alfonso F, et al : 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 35 : 2541-2619, 2014.
2) Komocsi A, Aradi D, Kehl D, et al : Meta-analysis of randomized trials on access site selection for percutaneous coronary intervention in ST-segment elevation myocardial infarction. Arch Med Sci 10 : 203-212, 2013.
P.174 掲載の参考文献
1) Rother J, Alberts MJ, Touze E, et al : Risk factor profile amd management of cerebrovascular parents in the REACH Registry. Cerebrovasc Dis 25 : 366-374, 2008.
2) Cacoub PP, Abola MT, Baumgartner I, et al : Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis 204 (2) : e86-e92, 2009.
3) ACC/AHA Guidelines for PAD. J Am Coll Cardiol 47 : 1239-1312, 2006.
4) Cassar A, Poldermans D, Rihal CS, Gersh BJ : The management of combined coronary artery disease and peripheral vascular disease. Eur Heart J 31 : 1565-1572, 2010.

IV 特殊な冠動脈病変に対するPCI治療の考え方

P.187 掲載の参考文献
1) Ko E, Natsuaki M, Toyofuku M, et al : Sirolimus-eluting stent implantation for ostial right coronary artery lesions : five-year outcomes from the j-Cypher registry. Cardiovasc Interv and Ther 29 : 200-208, 2014.
2) Lam MK, Sen H, Tandjung K, et al : Clinical outcome of patients with implantation of second-generation drug-eluting stents in the right coronary ostium : insights from 2-year follow-up of the TWENTE Trial. Catheter Cardiovasc Interv 85 : 524-531, 2015.
P.197 掲載の参考文献
1) Ielasi A, Chieffo A : Tools & techniques : left main coronary artery percutaneous coronary intervention. EuroIntervention 6 (8) : 1020-1021, 2011.
2) Chieffo A, Park SJ, Valgimigli M, et al : Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery : a multicenter registry. Circulation 116 (2) : 158-162, 2007.
3) Iakovou I, Ge L, Michev I, et al : Clinical and angiographic outcome after sirolimus-eluting stent implantation in aortoostial lesions. J Am Coll Cardiol 44 : 967-971, 2004.
4) Hsieh IC, Chen CC, Chang SH, et al : Acute and long-term outcomes of drug-eluting stent implantations in aorto-ostial, left anterior descending artery-ostial, and nonostial lesions. Catheter Cardiovasc Interv 82 : 727-734, 2013.
5) Al-Lamee R, Ielasi A, Latib A, et al : Comparison of long-term clinical and angiographic outcomes following implantation of bare metal stents and drug-eluting stents in aorto-ostial lesions. Am J Cardiol 108 (8) : 1055-1060, 2011.
6) Luz A, Hughes C, Magalhaes R, et al : Stent implantation in aorto-ostial lesions : long-term follow-up and predictors of outcome. EuroIntervention 7 (9) : 1069-1076, 2012.
7) Kim SW, Mintz GS, Ohlmann P, et al : Comparative intravascular ultrasound analysis of ostial disease in the left main versus the right coronary artery. J Invasive Cardiol 19 : 377-380, 2007.
8) Rubinshtein R, Ben-Dov N, Halon DA, et al : Geographic miss with aorto-ostial coronary stent implantation : insights from high-resolution coronary computed tomography angiography. EuroIntervention pii : 20130505-03, 2014.
9) Bolte J, Neumann U, Pfafferott C, et al : Incidence, management, and outcome of stent loss during intracoronary stenting. Am J Cardiol 88 : 565-567, 2001.
10) Park SJ, Kim YH, Park DW, et al : Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv 2 (3) : 167-177, 2009.
11) Chieffo A, Park SJ, Meliga E, et al : Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery : a multicentre registry. Eur Heart J 29 (17) : 2108-2115, 2008.
12) Lee SW, Hong MK, Kim YH, et al : Bail-out stenting for left main coronary artery dissection during catheter-based procedure : acute and long-term results. Clin Cardiol 27 : 393-395, 2004.
13) Ellis SG, Ajluni S, Arnold AZ, et al : Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation 90 : 2725-2730, 1994.
14) Ruda-Vega M : Aortic dissection-exceedingly rare complication of coronary angioplasty. Cathet Cardiovasc Diagn 42 : 416, 1997.
15) Kovac JD, de Bono DP : Cardiac catheter complications related to left main stem disease. Heart 76 : 76-78, 1996.
P.207 掲載の参考文献
1) Medina A, Suarez de Lezo J, Pan M : A new classification of coronary bifurcation lesions. Rev Esp Cardiol 59 : 183, 2006.
2) 山本匡, 岩崎清, 新井淳, ほか : Clinical Results of Three-Time-Balloon-Inflation Method Performed in Elective PCI Cases. 生体医工学 51 : 350-356, 2013.
3) McGeoch RJ, Tanaka K, Overgaard CB, et al : Proximal optimization technique and kissing balloon inflations with the bioresorbable vascular scaffold for coronary bifurcation percutaneous coronary intervention. Can J Cardiol 30 : 1461 e5-7, 2014.
4) Mortier P, Hikichi Y, Foin N, et al : Provisional stenting of coronary bifurcations : insights into final kissing balloon post-dilation and stent design by computational modeling. JACC Cardiovasc Interv 7 : 325-333, 2014.
5) Burzotta F, Trani C, Sianos G : Jailed balloon protection : a new technique to avoid acute side-branch occlusion during provisional stenting of bifurcated lesions. Bench test report and first clinical experience. EuroIntervention 5 : 809-813, 2010.
6) Singh J, Patel Y, Depta JP, et al : A modified provisional stenting approach to coronary bifurcation lesions : clinical application of the "jailed-balloon technique". J Interv Cardiol 25 : 289-296, 2012.
P.221 掲載の参考文献
1) Kim YH, Park DW, Ahn JM, et al : Everolimus-eluting stent implantation for unprotected left maincoronary artery stenosis. The PRECOMBAT-2 (Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease) study. JACC Cardiovasc Interv 5 (7) : 708-717, 2012.
P.229 掲載の参考文献
1) Hachamovitch R, Hayes SW, Friedman JD, et al : Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 107 : 2900-2907, 2003.
2) Koo BK, Lee SP, Lee JH, et al : Assessment of clinical, electrocardiographic, and physiological relevance of diagonal branch in left anterior descending coronary artery bifurcation lesions. JACC Interv 5 : 1126-1132, 2012.
3) Dou K, Zhang D, Xu B, et al : An Angiographic Tool for Risk Prediction of Side Branch Occlusion in Coronary Bifurcation Intervention. The RESOLVE Score System (Risk prEdiction of Side branch OccLusion in coronary bifurcation interVEntion). JACC Interv 8 : 39-46, 2015.
4) Hildick-Smith D, Lassen JF, Albiero R, et al : Consensus from the 5th European Bifurcation Club meeting. EuroIntervention 6 : 34-38, 2010.
5) Burzotta F, Trani C, Sianos G : Jailed balloon protection : a new technique to avoid acute side-branch occlusion during provisional stenting of bifurcated lesions. Bench test report and first clinical experience. EuroIntervention 5 : 809-813, 2010.
6) Murasato Y, Finet G, Foin N : Final kissing balloon inflation : the whole story. EuroIntervention ll supplV : V81-V85, 2015.
7) Murasato Y, Iwasaki K, Yamamoto T, et al : Optimal kissing balloon inflation after single-stent deployment in a coronary bifurcation model. EuroIntervention 10 : 934-941, 2014.
P.239 掲載の参考文献
1) Shah BN, Khattar RS, Senior R : The hibernating myocardium : current concepts, diagnostic dilemmas, and clinical challenges in the post-STICH era. Eur Heart J 34 : 1323-1336, 2013.
P.245 掲載の参考文献
1) Akins CW, Daggett WM, Vlahakes GJ, et al : Cardiac operations in patients 80 years old and older. Ann Thorac Surg 64 (3) : 606-614, 1997.
2) Kvidal P, Bergstrom R, Horte LG, Stahle E : Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 35 (3) : 747-756, 2000.
3) Ross J Jr., Braunwald E : Aortic stenosis. Circulation 38 (1 Suppl) : 61-67, 1968.
4) Nishimura RA, Otto CM, Bonow RO, et al : 2014 AHA/ACC guideline for the management of patients with valvular heart disease : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 (22) : e57-185, 2014.
5) Goel SS, Agarwal S, Tuzcu EM, et al : Percutaneous coronary intervention in patients with severe aortic stenosis : implications for transcatheter aortic valve replacement. Circulation 125 (8) : 1005-1013, 2012.
6) Goel SS, Ige M, Tuzcu EM, et al : Severe aortic stenosis and coronary artery disease--implications for management in the transcatheter aortic valve replacement era : a comprehensive review. J Am Coll Cardiol 62 (1) : 1-10, 2013.
P.251 掲載の参考文献
1) Yousefzai R, Bajaj N, Krishnaswamy A, et al : Outcomes of patients with ischemic mitral regurgitation undergoing percutaneous coronary intervention. Am J Cardiol 114 : 1011-1017, 2014.
2) Pastorius CA, Henry TD, Harris KM : Long-term outcomes of patients with mitral regurgitation undergoing percutaneous coronary intervention. Am J Cardiol 100 : 1218-1223, 2007.
3) Aklog L, Filsoufi F, Flores KQ, et al : Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation 104 : I68-75, 2001.
4) Kang DH, Sun BJ, Kim DH, et al : Percutaneous versus surgical revascularization in patients with ischemic mitral regurgitation. Circulation 124 : S156-162, 2011.
5) Byrne JG, Leacche M, Unic D, et al : Staged initial percutaneous coronary intervention followed by valve surgery ("hybrid approach") for patients with complex coronary and valve disease. J Am Coll Cardiol 45 : 14-18, 2005.
6) Campwala SZ, Bansal RC, Wang N, et al : Factors affecting regression of mitral regurgitation following isolated coronary artery bypass surgery. Eur J Cardiothorac Surg 28 : 104-108, 2005.
P.272 掲載の参考文献
1) 川崎富作 : 指趾の特異的落屑を伴う小児の急性熱性皮膚粘膜淋巴腺症候群 (自験例50例の臨床的観察). アレルギー 16 : 178-222, 1967.
2) Kato H, Sugimura T, Akagi T, et al : Long-Term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94 : 1379-1385, 1996.
3) Suzuki A, Kamiya T, Arakaki Y, et al : Fate of coronary arterial aneurysms in Kawasaki desease. Am J Cardiol 74 : 822-824, 1994.
4) Inokuchi R, Kurata H, Harada M, et al : Coronary artery Aneurysms after adult-onset Kawasaki desease. Circulation 127 : 1636-1637, 2013.
5) 川崎病心臓血管後遺症の診断と治療に関するガイドライン (2013年改訂版).
6) Ogawa S, Fukazawa R, Ohkubo T, et al : Silent myocardial ischemia in Kawasaki disease : evaluation of percutaneous transluminal coronary angioplasty by dobutamine stress testing. Circulation 96 : 3384-3389, 1997.
7) Ishii M, Ueno T, Ikeda H, et al : Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease : quantitative coronary artery angiography and intravascular ultrasound imaging study. Circulation 105 : 3004-3010, 2002.
8) 石井正浩 : 川崎病冠動脈後遺症へのカテーテル治療. 心臓 41 : 879-885, 2009.

V PCI時にきたした重症合併症への対応

P.281 掲載の参考文献
1) Warkentin TE, Greinacher A, Koster A, Lincoff AM : Treatment and prevention of heparin-induced thrombocytopenia : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133 : 340S-380S, 2008.
2) 角谷誠 : ヘパリン起因性血小板減少症 (HIT). 合併症克服トラブルシューティング (及川裕二編), メジカルビュー社, 東京, 2012, p116.
3) Warkentin TE : How I diagnose and manage HIT. Hematology Am Soc Hematol Educ Program 2011 : 143-149, 2011.
4) Lo GK, Warkentin TE, Sigouin CS, et al : Evaluation of pretest clinical score (4T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 4 : 759-765, 2006.
5) Matsuo T, Suzuki S, Matsuo M, Kobayashi H : Preexisting antibodies to platelet factor 4-heparin complexes in patients with acute coronary syndrome who have no history of heparin exposure. Pathophysiol Haemost Thromb 34 : 18-22, 2005.
6) Walenga JM, Jeske WP, Messmore HL : Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia. J Thromb Thrombolysis 10 : 13-20, 2000.

最近チェックした商品履歴

Loading...